These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2296627)

  • 1. Evaluation and comparison of the interaction between alcohol and moclobemide or clomipramine in healthy subjects.
    Berlin I; Cournot A; Zimmer R; Pedarriosse AM; Manfredi R; Molinier P; Puech AJ
    Psychopharmacology (Berl); 1990; 100(1):40-5. PubMed ID: 2296627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of moclobemide on psychomotor performance and cognitive function.
    Fairweather DB; Kerr JS; Hindmarch I
    Int Clin Psychopharmacol; 1993; 8(1):43-7. PubMed ID: 8473720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.
    Berlin I; Zimmer R; Thiede HM; Payan C; Hergueta T; Robin L; Puech AJ
    Br J Clin Pharmacol; 1990 Dec; 30(6):805-16. PubMed ID: 1705137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of moclobemide on autonomic and cognitive functions in healthy volunteers.
    Siepmann M; Handel J; Mueck-Weymann M; Kirch W
    Pharmacopsychiatry; 2004 Mar; 37(2):81-7. PubMed ID: 15048616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative investigation of the effect of moclobemide and toloxatone on monoamine oxidase activity and psychometric performance in healthy subjects.
    Dingemanse J; Berlin I; Payan C; Thiede HM; Puech AJ
    Psychopharmacology (Berl); 1992; 106 Suppl():S68-70. PubMed ID: 1546145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of moclobemide and mianserin on highway driving, psychometric performance and subjective parameters, relative to placebo.
    Ramaekers JG; Swijgman HF; O'Hanlon JF
    Psychopharmacology (Berl); 1992; 106 Suppl():S62-7. PubMed ID: 1546144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimensional assessment of onset of action of antidepressants: a comparative study of moclobemide vs. clomipramine in depressed patients with blunted affect and psychomotor retardation.
    Jouvent R; Le Houezec J; Payan C; Mikkelsen H; Fermanian J; Millet V; Dufour H
    Psychiatry Res; 1998 Jul; 79(3):267-75. PubMed ID: 9704873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin syndrome--clomipramine too soon after moclobemide?
    Gillman PK
    Int Clin Psychopharmacol; 1997 Nov; 12(6):339-42. PubMed ID: 9547136
    [No Abstract]   [Full Text] [Related]  

  • 9. Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
    J Affect Disord; 1993 Jun; 28(2):105-16. PubMed ID: 8354766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin syndrome caused by a clomipramine-moclobemide interaction.
    Dardennes RM; Even C; Ballon N; Bange F
    J Clin Psychiatry; 1998 Jul; 59(7):382-3. PubMed ID: 9714270
    [No Abstract]   [Full Text] [Related]  

  • 11. A risk-benefit assessment of moclobemide in the treatment of depressive disorders.
    Norman TR; Burrows GD
    Drug Saf; 1995 Jan; 12(1):46-54. PubMed ID: 7741983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial.
    Larsen JK; Holm P; Mikkelsen PL
    Acta Psychiatr Scand; 1984 Sep; 70(3):254-60. PubMed ID: 6388247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder.
    Krüger MB; Dahl AA
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 1():S19-24. PubMed ID: 10361962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxonidine and cognitive function: interactions with moclobemide and lorazepam.
    Wesnes K; Simpson PM; Jansson B; Grahnén A; Weimann HJ; Küppers H
    Eur J Clin Pharmacol; 1997; 52(5):351-8. PubMed ID: 9272403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressants, alcohol and psychomotor performance.
    Tiller JW
    Acta Psychiatr Scand Suppl; 1990; 360():13-7. PubMed ID: 2248062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin syndrome caused by a moclobemide-clomipramine interaction.
    Spigset O; Mjörndal T; Lövheim O
    BMJ; 1993 Jan; 306(6872):248. PubMed ID: 8443525
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical pharmacology of moclobemide during chronic administration of high doses to healthy subjects.
    Dingemanse J; Wood N; Guentert T; Oie S; Ouwerkerk M; Amrein R
    Psychopharmacology (Berl); 1998 Nov; 140(2):164-72. PubMed ID: 9860107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects.
    Allen D; Curran HV; Lader M
    Eur J Clin Pharmacol; 1991; 40(4):355-62. PubMed ID: 2050170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of oral moclobemide in healthy human subjects and effects on MAO-activity in platelets and excretion of urine monoamine metabolites.
    Wiesel FA; Raaflaub J; Kettler R
    Eur J Clin Pharmacol; 1985; 28(1):89-95. PubMed ID: 3987791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single oral doses of amisulpride do not enhance the effects of alcohol on the performance and memory of healthy subjects.
    Mattila MJ; Patat A; Seppälä T; Kalska H; Jalava ML; Vanakoski J; Lavanant C
    Eur J Clin Pharmacol; 1996; 51(2):161-6. PubMed ID: 8911882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.